News Sentiment

RVMD sentiment intelligence

Revolution Medicines Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 60 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 186.16 Week of 17 Jul 2026
Weighted tone 60/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.4% over one week, +14.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Revolution Medicines, Inc. (RVMD) Q3 2024 Earnings Report - Results, Call & Slides

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -0.4% Price digesting
Trend fit Trend active 14.2% over four weeks
Fair value 227.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 27
Neutral 31
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
Stock Titan 6
Simply Wall Street 5
MT Newswires 4
TradingView 4
Quiver Quantitative 3
GlobeNewswire 3
Investing.com 3

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 22
Analyst action 5
Regulatory and legal 4
Deals and strategy 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
grafa.com Direct company coverage

Revolution Medicines reports zoldonrasib pancreatic cancer data

Revolution Medicines reported a high treatment response rate of up to 82% for its zoldonrasib combinations in patients with RAS G12D metastatic pancreatic cancer, causing company shares to rise. These Phase 1/2 data, presented at the ESMO GI 2026 Congress, support the initiation

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 13:13
Source
grafa.com
Investing.com Canada Direct company coverage

Form 4 Revolution Medicines Inc For: 1 July By Investing.com

This article announces the filing of Form 4 for Revolution Medicines Inc. on July 1st. It also provides a market overview with current values for various indices, commodities, and bonds, along with trending news and market movers. The primary content focuses on the Form 4 filing

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 22:40
Source
Investing.com Canada
Stock Titan Direct company coverage

Revolution Medicines (NASDAQ: RVMD) director sells 5,580 shares, exercises options

Revolution Medicines director Sushil Patel exercised stock options for 2,955 shares and sold 5,580 shares of RVMD common stock on June 29, 2026. The sales were part of a pre-arranged Rule 10b5-1 trading plan and were executed at weighted-average prices ranging from $182.93 to $19

Tone
Negative 41/100
Event
Market update
Published
01 Jul 2026 22:40
Source
Stock Titan
Investing.com Canada Direct company coverage

Revolution Medicines director Sushil Patel sells $1.05m in stock By Investing.com

Revolution Medicines director Sushil Patel sold $1.05 million worth of company stock through a pre-arranged trading plan, following the exercise of stock options. These sales occurred when the stock was trading near its 52-week high, with InvestingPro analysis suggesting the stoc

Tone
Negative 40/100
Event
Market update
Published
01 Jul 2026 22:40
Source
Investing.com Canada
TradingView Direct company coverage

Price to sales forward of Revolution Medicines, Inc. – NASDAQ:RVMD

This article provides a brief financial update for Revolution Medicines, Inc. (NASDAQ: RVMD), focusing on its forward price-to-sales ratio. It indicates current trading information and highlights that the market is closed with no recent trades. The content is primarily a data poi

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 18:13
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Revolution Medicines, Inc. – BMV:RVMD

This article provides the "Price to earnings forward" metric for Revolution Medicines, Inc. (BMV:RVMD). The content appears to be a financial data point from TradingView, indicating that the market for RVMD was closed with no trades recorded at the time of publication. The articl

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 05:41
Source
TradingView